Parkinson's research is accelerating with new targets. Here are the most promising trials recruiting in 2025 and who is eligible.
About this article: Educational and informational only. Does not constitute medical advice or eligibility guidance. Always discuss clinical trial options with your care team. Verify current trial status at ClinicalTrials.gov.
What You Need to Know
The most promising Parkinson's disease clinical trials in 2025, covering alpha-synuclein therapies, GLP-1 agonists, gene therapy, and motor symptom studies.
Find recruiting trials for your condition
Search ClinicalTrials.gov in real time — matched to your profile, explained in plain English. Free, no account required.
Start Free Search →Explore Trials for This Condition
For condition-specific trial information, including common eligibility requirements, trial types, and direct search links, visit the Tidera condition page:
How Tidera Health Can Help
Tidera Health searches ClinicalTrials.gov in real time and uses AI to explain which trials may be relevant to your condition, age, location, and treatment history. It's free, requires no account, and stores no health data.
Enter your condition and location to see currently recruiting trials matched to your profile — with plain-English eligibility explanations and questions to ask the research coordinator.